Literature DB >> 31104472

Causes of Mortality After Percutaneous Coronary Intervention.

Rory S Bricker1, Javier A Valle1,2, Mary E Plomondon1,2, Ehrin J Armstrong1,2, Stephen W Waldo1,2.   

Abstract

Background Public reporting of percutaneous coronary intervention (PCI) often uses periprocedural (30 days) mortality as a surrogate for procedural quality, though it is unclear how often death is attributable to the PCI. The cause of death among patients who died within 30 days of PCI in a national healthcare system was thus evaluated. Methods and Results We identified all patients who died within 30 days of PCI in the Veterans Affairs (VA) Healthcare System from October 2005 to September 2016. Causes of death were classified through a detailed chart review using definitions from the Academic Research Consortium. Of 115 191 patients undergoing PCI during the study period, 1674 patients died within 30 days of PCI (1.5%). A detailed chart review demonstrated that the majority of patients had an undifferentiated death not definitively attributable to a single cause (981, 59%), whereas a minority had a death directly attributable to a cardiovascular cause (467, 28%). The majority of cardiovascular deaths were unrelated to the interventional procedure (335, 72%). Cardiovascular deaths were more likely to occur in the inpatient setting (95%) compared with noncardiac (89%) or undifferentiated deaths (49%, P<0.001). Conclusions A minority of deaths occurring after percutaneous revascularization were definitively due to cardiac causes, with an even smaller proportion related to the PCI. With such a small proportion of deaths directly attributable to the PCI, these data suggest that 30-day mortality may be an inappropriate metric to assess procedural quality.

Entities:  

Keywords:  cause of death; death; mortality; percutaneous coronary intervention; veterans

Mesh:

Year:  2019        PMID: 31104472     DOI: 10.1161/CIRCOUTCOMES.118.005355

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  6 in total

1.  Association Between Current and Future Annual Hospital Percutaneous Coronary Intervention Mortality Rates.

Authors:  Alexander T Sandhu; Shun Kohsaka; Jay Bhattacharya; William F Fearon; Robert A Harrington; Paul A Heidenreich
Journal:  JAMA Cardiol       Date:  2019-11-01       Impact factor: 14.676

2.  Report on the nature, characteristics, and outcomes of the Japanese healthcare system.

Authors:  Tatsuya Kondo
Journal:  Glob Health Med       Date:  2022-02-28

3.  Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.

Authors:  Mario Gaudino; Irbaz Hameed; Michael E Farkouh; Mohamed Rahouma; Ajita Naik; N Bryce Robinson; Yongle Ruan; Michelle Demetres; Giuseppe Biondi-Zoccai; Dominick J Angiolillo; Emilia Bagiella; Mary E Charlson; Umberto Benedetto; Marc Ruel; David P Taggart; Leonard N Girardi; Deepak L Bhatt; Stephen E Fremes
Journal:  JAMA Intern Med       Date:  2020-12-01       Impact factor: 21.873

4.  Reperfused hemorrhagic myocardial infarction in rats.

Authors:  Anand R Nair; Eric A Johnson; Hsin-Jung Yang; Ivan Cokic; Joseph Francis; Rohan Dharmakumar
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

5.  Symptomatic intracerebral hemorrhage after non-emergency percutaneous coronary intervention: Incidence, risk factors, and association with cardiovascular outcomes.

Authors:  Mervyn Jun Rui Lim; Yilong Zheng; Rodney Yu-Hang Soh; Qi Xuan Joel Foo; Andie Hartanto Djohan; Vincent Nga Diong Weng; Jamie Sin-Ying Ho; Tseng Tsai Yeo; Hui-Wen Sim; Tiong-Cheng Yeo; Huay-Cheem Tan; Mark Yan-Yee Chan; Joshua Ping-Yun Loh; Ching-Hui Sia
Journal:  Front Cardiovasc Med       Date:  2022-09-16

6.  Perceptions of Public and Nonpublic Reporting of Interventional Cardiology Outcomes and Its Impact on Practice: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Justin Morrison; Mary E Plomondon; Colin I O'Donnell; Jay Giri; Jacob A Doll; Javier A Valle; Stephen W Waldo
Journal:  J Am Heart Assoc       Date:  2019-11-12       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.